The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.
about
Bone and TNF in rheumatoid arthritis: clinical implicationsSpanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisEffect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trialsEfficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study.The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trialsRadiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebAssessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trialOutcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis.Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH studyEfficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations.Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.Effectiveness of golimumab in clinical management of patients with rheumatoid arthritisGolimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study throughTofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trialCertolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III stRecovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial.Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.The expanding role of therapeutic antibodies.Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review.Intravenous golimumab in rheumatoid arthritis.Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety.Evaluation of golimumab for the treatment of patients with active rheumatoid arthritis.Golimumab: A Review in Inflammatory Arthritis.Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trialsMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis.Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial.Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan.Assessment of 3-month changes in bone microstructure under anti-TNFα therapy in patients with rheumatoid arthritis using high-resolution peripheral quantitative computed tomography (HR-pQCT).Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?Guidelines for the drug treatment of rheumatoid arthritis.Comparative effectiveness of biologic antirheumatic therapies in rheumatoid arthritis after failure to respond to a first TNF inhibitor.Golimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function finEfficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial.Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications.Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial.
P2860
Q26777895-3E010073-376F-4309-B84A-6F25F4B9D45CQ26852081-87A591BA-7B7B-4B36-8650-43523B16CE20Q28543128-23BCD20C-ED99-4632-81B3-322CCDECA44DQ33956485-31DFC67E-5122-4019-9B60-55CFEDE20150Q34364057-238F7DCC-F03D-46E1-9688-6A778649776EQ34607591-71BB0715-9472-4E36-90C5-CD1290C7AEE4Q35249589-BCCC9381-6139-4605-B734-5B18421434C5Q35540004-CCA93557-424C-456C-86FB-647713F2DE9DQ35605449-BFD7BEFA-2E5C-4007-BB82-E274AF2F1DF3Q35954700-4BD26EA5-ABA7-4141-9922-8E7C4A426851Q36023494-68C96F62-07EE-4C9B-8784-59DDD1432DBCQ36085461-3F2FC39B-8DE8-47FF-98C4-42076953E011Q36300479-D16CEB4A-14E7-4FC6-8C94-C3DDAEE1046DQ36456822-38F9F9D6-1897-4884-BE1C-1AFA8CAD2686Q36767782-0D7A08F5-090F-4C61-BFDB-0E9861D29352Q37130039-5853F8C7-42C2-4B6B-9F2A-F29E528EB3DBQ37312668-4C7EB92E-5BE0-4346-A77B-0109EB7646A6Q37604489-13B08B09-F6B4-4BF0-BBE3-B4CB17D43338Q37706297-057745B1-358A-4D5D-A442-71DB26DE3122Q38176549-F9BDB4EC-D7DD-427B-9A2A-BE4A498AD086Q38182645-E00C7A55-6DE7-4168-928B-71811074B789Q38186577-DDE87556-3A06-4349-9965-D5CB369D755AQ38211958-58ECA0DC-3B37-4F54-8ACA-C3D206E31626Q38364465-9EDF5C84-1743-4094-8CD4-EC75B6612533Q38711889-3F881A35-5F41-45FC-BC68-0ABA6D598E96Q38771878-8DF459C0-3862-44B0-AB04-5E1F3D8FB738Q38818233-3EBCBE0D-EB9A-4419-ABC8-F62A93E6283EQ38939820-42FE684C-5DB2-4C0E-847A-81AC1188C5A2Q38998373-85AC6818-967F-4C7C-BFB6-4AF3F19DA864Q39999268-A0912464-BEF1-4AE5-94E1-FFE2FA27B4EAQ40948833-EE73967C-6D7A-4A99-AC60-263C0AB37BD8Q41127155-1B335C79-03BE-446A-8B15-18FDC8359808Q42161702-306D7177-D5DE-46DF-B67F-2E7850985007Q42245160-8258A907-1BAB-46FA-8E31-5846ADDB3C5DQ43675571-3FC4FF1B-B4AB-4C7A-966C-C419B14DAE45Q44503809-89BEB8AB-CC3C-4382-A318-90F55472CB53Q44911715-BB4EA519-DE6C-4E8D-A5C6-A81E9AD6CA03Q46030948-3BCDECAD-0FA3-49E2-9AED-620776F237DBQ47800990-06167E06-20FC-4624-900E-A421A1B1F2AEQ47886376-947CF278-3086-4F32-BE3B-F89C031F6215
P2860
The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The effects of golimumab on ra ...... ab after methotrexate therapy.
@ast
The effects of golimumab on ra ...... ab after methotrexate therapy.
@en
The effects of golimumab on ra ...... ab after methotrexate therapy.
@en-gb
The effects of golimumab on ra ...... ab after methotrexate therapy.
@nl
type
label
The effects of golimumab on ra ...... ab after methotrexate therapy.
@ast
The effects of golimumab on ra ...... ab after methotrexate therapy.
@en
The effects of golimumab on ra ...... ab after methotrexate therapy.
@en-gb
The effects of golimumab on ra ...... ab after methotrexate therapy.
@nl
prefLabel
The effects of golimumab on ra ...... ab after methotrexate therapy.
@ast
The effects of golimumab on ra ...... ab after methotrexate therapy.
@en
The effects of golimumab on ra ...... ab after methotrexate therapy.
@en-gb
The effects of golimumab on ra ...... ab after methotrexate therapy.
@nl
P2093
P2860
P50
P356
P1476
The effects of golimumab on ra ...... ab after methotrexate therapy.
@en
P2093
Anna Baratelle
Anna Beutler
Edward C Keystone
Elizabeth C Hsia
Mahboob U Rahman
Mark C Genovese
Roy Fleischmann
Weichun Xu
P2860
P304
P356
10.1002/ART.30263
P577
2011-05-01T00:00:00Z
P5875
P6179
1006263968